Lawtons Drugs

lawtons.ca

As a parent company and a strong supporter of Lawtons Drugs, Sobeys core values reflect the commitment and convictions that have helped shape the company over the past 100 years. Since our 1907 beginning as a small pharmacy in Newfoundland, Lawtons Drugs has portrayed integrity, commitment to its employees, and a desire to consistently exceed customer expectations in service, value and product selection. Lawtons Drugs has since grown to 80 locations in Atlantic Canada with plans to expand even further. Our pharmacy services complement customers’ prescriptions and help them manage their family’s medication and health care needs. Lawtons Drugs has a full line of home healthcare solutions, beauty, cosmetics, convenience and giftware products to suit everyone’s needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

BIOCORP AND MERCK KGAA, DARMSTADT, GERMANY, SIGN A NEW PARTNERSHIP FOR SMART DRUG DELIVERY

BIOCORP and Merck KGaA, Darmstadt, Germany | October 11, 2022

news image

BIOCORP a French company specialized in the design, development, and manufacturing of innovative medical devices, and Merck KGaA, Darmstadt, Germany, a leading science, and technology company, have entered into an agreement for the development and supply of a specific version of Mallya device as an accessory for one of Merck KGaA, Darmstadt, Germany's drug delivery devices. Manufactured in Clermont-Ferrand Mallya is a Bluetooth enabled clip-on device for pen injectors that col...

Read More

Pharmacy Market

INTEGRICHAIN AND VERATO PARTNER ON SECURING PATIENT PRIVACY DATA

PRNewswire | June 23, 2023

news image

IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, and Verato, the identity experts for healthcare, today announced a technology partnership. IntegriChain will utilize Verato's healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII). The vault receives and stores ident...

Read More

Pharma Tech

USFDA ACCEPTS BIOMARIN'S SNDA TO EXPAND USE OF VOXZOGO

BioMarin Pharmaceutical Inc. | March 08, 2023

news image

On March 7, 2023, BioMarin Pharmaceutical Inc., a global biotech company focused on improving lives via genetic discovery, announced that the US FDA has accepted its supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) for injection to expand the treatment of achondroplasia in children under the age of 5. Achondroplasia is a common form of disproportionate short stature. The FDA has set an action date of October 21, 2023, for the sNDA. The sNDA is supported by ...

Read More

Pharma Tech

JANSSEN SEEKS EUROPEAN COMMISSION APPROVAL OF A NEW INDICATION FOR CARVYKTI® FOR THE EARLIER TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY

Globenewswire | June 01, 2023

news image

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Type II variation application to the European Medicines Agency (EMA) seeking approval of a new indication for CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma. “The previous European Commission approval recognised the potential for cilta-cel to positively impact outcomes for peop...

Read More
news image

Pharma Tech

BIOCORP AND MERCK KGAA, DARMSTADT, GERMANY, SIGN A NEW PARTNERSHIP FOR SMART DRUG DELIVERY

BIOCORP and Merck KGaA, Darmstadt, Germany | October 11, 2022

BIOCORP a French company specialized in the design, development, and manufacturing of innovative medical devices, and Merck KGaA, Darmstadt, Germany, a leading science, and technology company, have entered into an agreement for the development and supply of a specific version of Mallya device as an accessory for one of Merck KGaA, Darmstadt, Germany's drug delivery devices. Manufactured in Clermont-Ferrand Mallya is a Bluetooth enabled clip-on device for pen injectors that col...

Read More
news image

Pharmacy Market

INTEGRICHAIN AND VERATO PARTNER ON SECURING PATIENT PRIVACY DATA

PRNewswire | June 23, 2023

IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, and Verato, the identity experts for healthcare, today announced a technology partnership. IntegriChain will utilize Verato's healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII). The vault receives and stores ident...

Read More
news image

Pharma Tech

USFDA ACCEPTS BIOMARIN'S SNDA TO EXPAND USE OF VOXZOGO

BioMarin Pharmaceutical Inc. | March 08, 2023

On March 7, 2023, BioMarin Pharmaceutical Inc., a global biotech company focused on improving lives via genetic discovery, announced that the US FDA has accepted its supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) for injection to expand the treatment of achondroplasia in children under the age of 5. Achondroplasia is a common form of disproportionate short stature. The FDA has set an action date of October 21, 2023, for the sNDA. The sNDA is supported by ...

Read More
news image

Pharma Tech

JANSSEN SEEKS EUROPEAN COMMISSION APPROVAL OF A NEW INDICATION FOR CARVYKTI® FOR THE EARLIER TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY

Globenewswire | June 01, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Type II variation application to the European Medicines Agency (EMA) seeking approval of a new indication for CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma. “The previous European Commission approval recognised the potential for cilta-cel to positively impact outcomes for peop...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us